The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
<iframe src="https://hindustansphere.com/embed/cluster/9c442425246107b0131bb5b3bd0002f7ed0704ba" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="U.S. regulators to examine testosterone therapy as use by menopausal women rises"></iframe>
The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
